Printer Friendly

Browse Multiple myeloma topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Precision BioSciences, SpringsWorks to evaluate PBCAR269A with nirogacestat. Sep 21, 2020 203
Poseida Therapeutics to present CAR-T manufacturing process optimization data. Sep 16, 2020 456
SpringsWorks Therapeutics enters collaboration, supply agreement with Janssen. Sep 14, 2020 203
Takeda Releases Disappointing Results from Phase 3 Clinical Trial Evaluating Ninlaro in Newly Diagnosed Multiple Myeloma. Sep 11, 2020 514
Cellectar Biosciences reports data on CLR 131 Phase 2 CLOVER-1 study. Drug overview Sep 9, 2020 178
LEUKAEMIA LEFT ME A FEW DAYS FROM DEATH BUT I DIDN'T KNOW IT; PATIENT SAVED FROM BLOOD CANCER BACKS NEW CAMPAIGN TO SPOT SIGNS. JANE TYLER News Reporter Sep 4, 2020 599
'Blood cancer patients at the highest risk if they get Covid'. aine fox newsdesk@walesonline.co.uk Aug 25, 2020 1043
Janssen Pharmaceutical Companies wins FDA approval for new DARZALEX combination regimen for treating multiple myeloma. Aug 21, 2020 263
Janssen Pharmaceutical Companies wins FDA approval for new DARZALEX combination regimen for treating multiple myeloma. Aug 21, 2020 267
Amgen Notes US FDA Approval For Kyprolis-Darzalex As Myeloma Treatment. Aug 21, 2020 218
BioLineRx achieves enrollment target in Phase 3 GENESIS trial. Aug 19, 2020 160
Cancer comes calling. Irfan Husain Aug 8, 2020 927
GlaxoSmithKline receives green light for bone marrow cancer drug. Aug 7, 2020 248
Seattle Genetics Achieves Milestone Payment Under Antibody-Drug Conjugate Collaboration with GlaxoSmithKline Triggered by Blenrep FDA Approval. Aug 7, 2020 402
TOP NEWS: US Regulator Approves Glaxo's Blenrep As Myeloma Treatment. Aug 6, 2020 233
bluebird bio reports Q2 EPS (36c), consensus ($2.60). Financial report Aug 5, 2020 268
Legend Biotech says China CDE recommends BTD for BCMA CAR-T cell therapy. Aug 5, 2020 274
Premier Research names new senior medical director. Aug 4, 2020 174
Premier Research names new senior medical director. Aug 4, 2020 170
MorphoSys And Incyte Celebrate US Green Light For Blood Cancer Drug. Aug 3, 2020 151
Bristol Myers Squibb, bluebird bio Submit Biologics License Application to FDA for Idecabtagene Vicleucel (Ide-cel, bb2121) for Adults with Relapsed and Refractory Multiple Myeloma. Jul 31, 2020 709
Genmab announces Janssen's 'positive' results from Phase 3 APOLLO study. Jul 31, 2020 188
Bristol Myers Squibb and bluebird bio submit cell therapy application to FDA. Jul 30, 2020 211
Bristol Myers Squibb and bluebird bio submit cell therapy application to FDA. Jul 30, 2020 207
First-ever bone marrow transplant conducted in UAE. Jul 28, 2020 510
GlaxoSmithKline says US advisory committee recommends blood cancer antibody approval. Jul 16, 2020 319
GSK's Belantamab Gets US Committee Nod But Awaiting FDA Green Light. Jul 15, 2020 165
Celyad announces FDA clearance of IND application for CYAD-211. Jul 14, 2020 231
Karyopharm reports preliminary Q2 XPOVIO sales $18.5M. Financial report Jul 14, 2020 295
FDA concerned about ocular toxicity into meeting on GSK's belantamab. Jul 10, 2020 201
DOC TONY'S HEARTACHE; Chief Medical Officer steps back to be with wife as she fights cancer; Dr Holohan quits over dying wife. NEIL LESLIE Jul 3, 2020 333
Blood Cancer Basics: Older adults are more prone to some types. There are a myriad of treatment options, and in some cases, a cure is possible. Disease/Disorder overview Jul 1, 2020 1370
A Simple and Rapid LC-MS/MS Method for Therapeutic Drug Monitoring of Lenalidomide. Neset Nesetoglu, Cem Kaplan, Serap Saglik Aslan and Durisehvar Ozer Unal Jun 30, 2020 3465
Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib. Robak, Pawel; Weglowska, Edyta; Drozdz, Izabela; Mikulski, Damian; Jarych, Dariusz; Ferlinska, Magda Jun 30, 2020 9336
PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma. Bai, Hua; Zhu, Yudi; Xu, Peipei; Chen, Bing Jun 30, 2020 4687
The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma. Zmorzynski, S.; Popek-Marciniec, S.; Styk, W.; Wojcierowska-Litwin, M.; Korszen- Pilecka, I.; Szudy- Jun 30, 2020 7743
A Comprehensive Biological and Clinical Perspective Can Drive a Patient-Tailored Approach to Multiple Myeloma: Bridging the Gaps between the Plasma Cell and the Neoplastic Niche. Solimando, Antonio Giovanni; Vacca, Angelo; Ribatti, Domenico Jun 30, 2020 12638
Abnormal PTBP1 Expression Sustains the Disease Progression of Multiple Myeloma. Bai, Hua; Chen, Bing Jun 30, 2020 5776
SpringsWorks Therapeutics: Dosing begins in Phase 1b study of nirogacestat. Jun 22, 2020 159
Affimed N.V. announces presentation of data on Genentech's RO7297089. Jun 22, 2020 382
Multi-titled volleyball coach Roger Gorayeb now cancer-free. Jun 21, 2020 375
Roger Gorayeb now cancer-free. Jun 21, 2020 254
Mum who had terrifying rashes for months told she was one of first Brits to get Covid-19; Sarah Churchill, from Bournemouth, Dorset, was told by doctors that she may have blood cancer or even HIV after medical tests were inconclusive, leaving her fearing for the future of her nine-year-old son. By, Neil Murphy & Ralph Blackburn Jun 11, 2020 694
In dad's memory Sisters: Siblings bring awareness to rare cancer. Submitted by Joe Trost, Buddy's HELPERS Jun 7, 2020 420
In their father's memory. Submitted by Joe Trost, Buddy's HELPERS Jun 7, 2020 420
Genmab granted Euuropean marketing authorization for SC formulation of DARZALEX. Jun 4, 2020 231
Sanofi says Sarclisa combination therapy showed superior PFS in relasped MM. Jun 2, 2020 674
Molecular mechanisms of thalidomide and its derivatives. Ito, Takumi; Handa, Hiroshi Jun 1, 2020 9569
FDA approves pomalidomide for Kaposi sarcoma. Mulcahy, Nick Jun 1, 2020 374
Listeria Cerebritis with Tumor Necrosis Factor Inhibition. Reilly, Eileen; Hwang, Justin May 31, 2020 3212
Karyopharm reports Phase 3 Boston data in ASCO presentation. May 28, 2020 355
Oncopeptides completes OCEAN phase three relapsed refractory multiple myeloma study. May 25, 2020 189
Oncopeptides completes OCEAN phase three relapsed refractory multiple myeloma study. May 25, 2020 185
Oncopeptides announces completion of enrolment in pivotal phase 3 study OCEAN. Report May 22, 2020 208
Oncopeptides announces completion of enrolment in pivotal phase 3 study OCEAN. Report May 22, 2020 203
Oncopeptides announces completion of enrolment in pivotal phase 3 study OCEAN. Report May 22, 2020 207
Precision BioSciences reports Q1 EPS (52c), consensus (52c). Financial report May 15, 2020 196
Janssen's BCMA CAR-T Therapy JNJ-4528 Showed Early, Deep and Durable Responses in Heavily Pretreated Patients with Multiple Myeloma. May 14, 2020 874
Mustang Bio announces presentations at ASGCT meeting. May 12, 2020 294
Bristol-Myers to present data from over 50 company-sponsored studies at ASCO20. May 11, 2020 179
Allogene Therapeutics expects inital data from Phase 1 UNIVERSAL trial in Q4. May 6, 2020 172
Amgen: KYPROLIS patents upheld against generic manufacturer. May 5, 2020 200
Janssen Biotech, Halozyme Therapeutics collaboration receives US FDA approval for DARZALEX FASPRO. May 4, 2020 310
Janssen Biotech, Halozyme Therapeutics collaboration receives US FDA approval for DARZALEX FASPRO. May 4, 2020 306
Johnson & Johnson's Janssen Gets Positive EU Opinion For Darzalex. May 1, 2020 179
Genmab announces FDA approval of Darzalex Faspro. May 1, 2020 170
Halozyme announces FDA approval of DARZALEX FASPRO for Janssen Biotech. May 1, 2020 162
Halozyme discloses Janssen receipt CHMP positive opinion for Darzalex. Apr 30, 2020 197
Arix Bioscience's Pharmaxis says myelofibrosis treatment well tolerated in clinical trial, advances to Phase 2. Apr 29, 2020 359
Arix Biosciences notes investee company Harpoon's US$50mln milestone receipt. Apr 28, 2020 167
Family's balcony marathon challenge. Apr 27, 2020 222
Family's balcony marathon challenge. Apr 27, 2020 222
Family's balcony marathon challenge. Apr 27, 2020 220
Family's balcony marathon challenge. Apr 27, 2020 222
Family's balcony marathon challenge. Apr 27, 2020 222
Family's balcony marathon challenge. Apr 27, 2020 222
Family's balcony marathon challenge. Apr 27, 2020 173
Family's balcony marathon challenge. Apr 27, 2020 222
Family's balcony marathon challenge. Apr 27, 2020 222
Family's balcony marathon challenge. Apr 27, 2020 222
MorphoSys, I-MAB announce 1st patient dosed in multiple myeloma study in China. Clinical report Apr 27, 2020 299
AstraZenecaAato trial blood cancer drug for coronavirus treatment. Apr 15, 2020 440
AstraZenecaAato trial blood cancer drug for coronavirus treatment. Apr 15, 2020 442
J&J Pharmaceutical worldwide operational sales ex-items grew 10.2%. Apr 14, 2020 191
Karyopharm to evaluate low dose selinexor as potential treatment for COVID-19. Apr 7, 2020 433
Check if you should be isolating for 12 weeks. Dr Miriam Stoppard DAILY VIRUS UPDATE Apr 1, 2020 250
Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells. Espagnolle, Nicolas; Hebraud, Benjamin; Descamps, Jean-Gerard; Gadelorge, Melanie; Joubert, Marie-Ve Report Mar 31, 2020 4536
Buschke scleredema: A case report. Shahid Ahmed, Kanwal Mushtaq, Zareen Saqib Sulehri and Arslan Chaudry Mar 31, 2020 725
Passengers in a fix after inter-city bus services suspended. Mar 21, 2020 326
Man dumped by girlfriend when doctor misdiagnosed terminal cancer as an STD; Tony Stevens, 40, from Royal Wootton Bassett, was told by a doctor he had an STD, but months later he was diagnosed with a rare type of blood cancer and given five years to live. By, Jamie Hawkins Mar 18, 2020 358
Precision BioSciences reports FY19 EPS ($2.21), consensus ($2.26). Financial report Mar 10, 2020 152
Takeda Provides Releases Disappointing Results for TOURMALINE-MM2 Phase 3 Trial. Mar 10, 2020 527
Parents of boy, 11, with blood cancer 'forced to pay [pounds sterling]5,000 in hospital parking bills'; Darcy Sturman has been at a children's ward in Sheffield since being diagnosed with leukaemia in September 2017. His parents Jo and Jay, from Louth, have paid [pounds sterling]5,000 on parking and [pounds sterling]7,000 on fuel already just to visit him. By, Jack Longstaff & Tanveer Mann Mar 8, 2020 580
New drug for cancer of bone marrow approved. Mar 4, 2020 586
Sanofi wins US FDA approval for Sarclisa, pomalidomide and dexamethasone combination to treat relapsed refractory multiple myeloma. Mar 3, 2020 267
Sanofi wins US FDA approval for Sarclisa, pomalidomide and dexamethasone combination to treat relapsed refractory multiple myeloma. Mar 3, 2020 263
Advances in oncology technology and free light chain testing. Zetlmeisl, Maureen Mar 1, 2020 1359
No stopping Gorayeb in PLDT return. Mar 1, 2020 340
Pulmonary Nocardia ignorata Infection in Gardener, Iran, 2017. Rahdar, Hossein A.; Gharabaghi, Mehrnaz A.; Bahador, Abbas; Shahraki-Zahedani, Shahram; Karami-Zaran Clinical report Mar 1, 2020 1294
Multiple Myeloma Mimicking a Small Vessel Vasculitis Presentation. Mejia-Zuluaga, Mateo; Lacouture, Jorge Andres; Gaviria, Maria Clara; Garces, Maria Adelaida; Mejia, Mar 1, 2020 3240
Hypercalcemic Encephalopathy as an Initial Presentation of Multiple Myeloma. Meena, Durga Shankar; Bohra, Gopal Krishana; Garg, Mahendra Kumar; Purohit, Abhishek; Kumar, Deepak; Mar 1, 2020 1860
KNOW WHAT TO LOOK FOR; Despite being relatively common, blood cancer warning signs can be easy to miss, writes Lisa Salmon. Lisa Salmon Feb 29, 2020 869
Types of paraproteinemia in patients with multiple myeloma: A cross-sectional study. Report Feb 29, 2020 2548
THE SYMPTOMS YOU NEED TO KNOW TO SPOT BLOOD CANCER; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. LISA SALMON Feb 25, 2020 864
THE SYMPTOMS YOU NEED TO KNOW TO SPOT BLOOD CANCER; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. LISA SALMON Feb 25, 2020 865
THE SYMPTOMS you NEED TO know TO SPOT blood cancer; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. Feb 25, 2020 862
THE SYMPTOMS you NEED TO know TO SPOT blood cancer; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. LISA SALMON Feb 25, 2020 877
THE SYMPTOMS you NEED TO know TO SPOT blood cancer; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. Feb 25, 2020 861
THE SYMPTOMS you NEED TO know TO SPOT blood cancer; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. LISA SALMON Feb 25, 2020 1060
THE SYMPTOMS you NEED TO know TO SPOT blood cancer; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. Feb 25, 2020 858
THE SYMPTOMS you NEED TO know TO SPOT blood cancer; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. LISA SALMON Feb 25, 2020 865
Caribou Biosciences Gains Access to ProMab Humanized scFv Targeting BCMA. Feb 25, 2020 328
THE SYMPTOMS YOU NEED TO KNOW TO SPOT BLOOD CANCER; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. LISA SALMON Feb 24, 2020 865
THE SYMPTOMS YOU NEED TO KNOW TO SPOT BLOOD CANCER; DESPITE BEING RELATIVELY COMMON, THE WARNING SIGNS CAN BE EASY TO MISS, WRITES LISA SALMON. LISA SALMON Feb 24, 2020 1061
Gas Used at Baxter Plant Draws Attention: Carcinogen releases cause health worries for AGs and residents. Friedman, Mark Feb 17, 2020 1319
Kleo announces FDA IND approval to proceed with multiple myeloma therapeutic of KP1237 & NK Cells combination. Feb 10, 2020 263
Kleo announces FDA IND approval to proceed with multiple myeloma therapeutic of KP1237 & NK Cells combination. Feb 10, 2020 259
Arix Bioscience investee company Autolus publishes encouraging additional data from blood cancer drug study. Jan 31, 2020 218
Roger Gorayeb getting 'stronger' amid battle with cancer. Jan 30, 2020 283
Doctor diagnosed with cancer determined to survive for teenage son's sake. Jan 22, 2020 258
Genmab reports grant of European Marketing Authorisation for DARZALEX in frontline multiple myeloma. Jan 21, 2020 203
Genmab reports grant of European Marketing Authorisation for DARZALEX in frontline multiple myeloma. Jan 21, 2020 199
Your risks for 7 types of cancer are reduced with physical activity. Linda Searing Special To The Washington Post Jan 20, 2020 312
We don't want your money, we want your time... Dad battling incurable blood cancer leading campaign to recruit thousands of lifesaving stem cell donors. Sallie Ehlen meets a man on a mission. Jan 16, 2020 613
Starton Therapeutics CEO talks through 2019 achievements and anticipated milestones in 2020. Jan 16, 2020 135
Reconstituting blood in humans to be boon for individuals suffering from blood cancer, sickle-cell anaemia: Study. ANI Jan 1, 2020 601
SELINEXOR OPENS OPTIONS TO TREAT REFRACTORY MYELOMA. Drug overview Jan 1, 2020 716
Is It T3 Thyrotoxicosis? A Case of Falsely Elevated Tri-Iodothyronine (T3) Levels Leading to a Diagnosis of Multiple Myeloma. Ram, Nanik; Furqan, Saira; Ahmed, Sibtain Jan 1, 2020 1902
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation. Staderini, Michela; Mannelli, Lara; Antonioli, Elisabetta; Puccini, Benedetta; Berti, Valentina; Mun Jan 1, 2020 2862
Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma. Zhang, Zhi-yao; Li, Yan-chen; Geng, Chuan-ying; Wang, Hui-juan; Chen, Wen-ming Dec 31, 2019 5395
Cancer-hit boy, 13, forced to travel 500-miles a week for treatment; Danial Graham has the rare blood cancer myelodysplastic syndrome and knows he must travel across Scotland to give himself the best possible chance of beating the cancer. By, Vivienne Aitken & Sam Elliott Dec 28, 2019 565
Croydon mum told by doctors she wouldn't see another Christmas defies odds to beat cancer; Sharon Gayle didn't expect to live past 2016 after being told she had just months to live. Sam Truelove Dec 24, 2019 890
Telo Genomics announces Multiple Myeloma collaboration with Mayo Clinic. Clinical report Dec 20, 2019 894
Pivotal DREAMM-2 study demonstrated a clinically meaningful overall response rate with belantamab mafodotin (GSK2857916) for patients with relapsed/refractory multiple myeloma. Dec 17, 2019 1732
DarzalexRegimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma. Dec 12, 2019 237
Dr Reddy's Laboratories unveils Bortezomib for Injection 3.5 mg/vial in the US. Dec 4, 2019 180
Dr Reddy's Laboratories unveils Bortezomib for Injection 3.5 mg/vial in the US. Dec 4, 2019 176
Woman told she was infertile after chemotherapy gives birth to 'miracle' son; Abi Flynn, a singer from Hove, East Sussex, underwent life-saving treatment after being diagnosed with blood cancer Hodgkin's Lymphoma in August 2016 when she was aged 26. By, Leah Fox Nov 28, 2019 900
Roth repeats Buy rating on Arix Bioscience's portfolio company Harpoon Therapeutics. Nov 23, 2019 415
Roth repeats Buy rating on Arix Bioscience's portfolio company Harpoon Therapeutics. Nov 23, 2019 413
Arix Bioscience portfolio company Harpoon agrees US$2.4bn deal with Abbvie. Nov 22, 2019 284
Arix Bioscience portfolio company Harpoon agrees US$2.4bn deal with Abbvie. Nov 22, 2019 286
Janssen Receives EU Marketing Authorisation for Darzalex in Combination with Lenalidomide and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible. Nov 21, 2019 601
Genmab receives marketing authorisation in Europe for DARZALEX (Daratumumab) in combination with lenalidomide and dexamethasone in frontline multiple myeloma. Nov 20, 2019 223
Genmab receives marketing authorisation in Europe for DARZALEX (Daratumumab) in combination with lenalidomide and dexamethasone in frontline multiple myeloma. Nov 20, 2019 219
Veteran who hit the trail even as he faced cancer. FRASER CLYNE Nov 16, 2019 909
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval. Shanthi Rexaline Nov 15, 2019 1538
Family rocks out to raise PS7,000 for cancer fund; Event: Concert in memory of mum. DANIEL BOAL Obituary Nov 12, 2019 329
Help the heroes I defeated. CHERYL MULLIN Deputy Print Editor cheryl.mullin@trinitymirror.com @cezmullin Nov 8, 2019 808
Dying soldier's last wish to save the men he was trying to kill; "They are living like dogs". Cheryl Mullin Nov 8, 2019 913
Lenalidomide Delays Progression in Smoldering Multiple Myeloma; Progression-free survival significantly longer with lenalidomide compared with observation. Nov 7, 2019 282
Calquence data to show improved progression-free survival in Phase III front-line chronic lymphocytic leukaemia trial at ASH 2019 Annual Meeting. Nov 7, 2019 363
Cellectis reports Q3 adjusted EPS (23c), consensus (80c). Financial report Nov 6, 2019 187
Allogene Therapeutics reports Q3 EPS (50c), consensus (54c). Financial report Nov 5, 2019 167
Karyopharm reports Q3 EPS (67c), consensus (84c). Financial report Nov 4, 2019 157
Karyopharm expects topline data from Phase 3 BOSTON study in early 2020. Clinical report Nov 4, 2019 130
The Chosen. Goldberg, Robert; Goldberg, Zach Nov 4, 2019 174
CHMP GRANTS EXPANDED USE OF DARZALEX. Nov 1, 2019 751
Quarterly Reports: A by the number look at the industry. Nov 1, 2019 762
Modulation of ERQC and ERAD: A Broad-Spectrum Spanner in the Works of Cancer Cells? Tax, Gabor; Lia, Andrea; Santino, Angelo; Roversi, Pietro Oct 31, 2019 11715
Young woman 'will never forget' day she was diagnosed with blood cancer at 22; Ellie Howitt, from Derby, was told she had Hodgkin's lymphoma on August 9 but staff at her pub have quickly rallied around her. By, Rachel Sutherland Oct 31, 2019 814
Dad hid alcohol in walls for when he walked the dog as he drank 10 pints of cider and a bottle of Jack Daniels a day; Chris said he would ask people to bring alcohol into hospital while being treated for blood cancer. Anna Lewis Oct 31, 2019 1307
Cellectis says first patient dosed in UCARTCS1 clinical trial. Oct 29, 2019 139
Mum tells of heartbreaking choice to not bond with newborn son after her cancer diagnosis; 'The consultant told me, 'Please don't Google'. But I did and, from what I read, I was sure I had just months to live'. Amardeep Bassey Oct 27, 2019 1071
Mum tells of heartbreaking choice to not bond with newborn son after her cancer diagnosis; 'The consultant told me, 'Please don't Google'. But I did and, from what I read, I was sure I had just months to live'. Amardeep Bassey Oct 27, 2019 1071
Mum tells of heartbreaking choice to not bond with newborn son after her cancer diagnosis; 'The consultant told me, 'Please don't Google'. But I did and, from what I read, I was sure I had just months to live'. Amardeep Bassey Oct 27, 2019 1071
Mum tells of heartbreaking choice to not bond with newborn son after her cancer diagnosis; 'The consultant told me, 'Please don't Google'. But I did and, from what I read, I was sure I had just months to live'. Amardeep Bassey Oct 27, 2019 1071
Mum tells of heartbreaking choice to not bond with newborn son after her cancer diagnosis; 'The consultant told me, 'Please don't Google'. But I did and, from what I read, I was sure I had just months to live'. Amardeep Bassey Oct 27, 2019 1071
Mum tells of heartbreaking choice to not bond with newborn son after her cancer diagnosis; 'The consultant told me, 'Please don't Google'. But I did and, from what I read, I was sure I had just months to live'. Amardeep Bassey Oct 27, 2019 1071
The precious scan picture that shows pregnant cancer patient Roberta Burton's baby is doing well; Northumberland mum who is battling rare blood cancer while expecting her third child tells of relief as tumours shrink. Sophie Doughty Oct 25, 2019 604
I loved baby Fraser but I didn't want to bond with him as I thought that if I was going to die then it would be kinder on him if he hadn't got to know me; cancer mum's TORMENT BEFORE TREATMENT BOOST Brave Hannah tells of emotional turmoil after joy of having tot turned to agony.. and how she's learned never to give up on life. JENNY MORRISON reporters@dailyrecord.co.uk Oct 24, 2019 1118
Mum's heartbreaking choice to not bond with newborn son after cancer diagnosis; Hannah Toohill, from Scotland, thought it would be kinder if son Fraser never got to know her -but months later had a change of heart. By, Jenny Morrison Oct 24, 2019 796
Ex-Wolf Geoff takes on his final Tour ride; A FORMER Wolves midfielder is set to take on his final Tour de France cycling challenge next year to raise awareness of blood cancer. Oct 23, 2019 327
MorphoSys--MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China--14/10/2019. Oct 23, 2019 413
Genmab reports issue of positive opinion by CHMPrecommending DARZALEX in combination with lenalidomide and dexamethasone in frontline multiple myeloma. Oct 21, 2019 250
Genmab reports issue of positive opinion by CHMPrecommending DARZALEX in combination with lenalidomide and dexamethasone in frontline multiple myeloma. Oct 21, 2019 251
Genmab reports issue of positive opinion by CHMPrecommending DARZALEX in combination with lenalidomide and dexamethasone in frontline multiple myeloma. Oct 21, 2019 246
Johnson & Johnson's Darzalex Gets Recommendation For Expanded Use. Oct 21, 2019 250
Johnson & Johnson (NYSE: JNJ) - CHMP Grants Positive Opinion for Expanded Use of Janssen's Darzalex[R] (daratumumab) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible -- 18/10/2019. Oct 21, 2019 345
Multiple Myeloma Treatment Market Size, Technology, Regional Scope, Growth Opportunity, Key Highlights, Demand and Trends, Forecast To 2023. Oct 18, 2019 929
Senior hematologist highlights relevance of medication for blood cancer. Oct 18, 2019 338
Genmab announces positive CHMP opinion for DARZALEX maketing authorization. Oct 18, 2019 108
Study Uncovers Racial Gaps in Treatment of Multiple Myeloma. Oct 18, 2019 406
Treatment of blood cancer by medicines instead of bone marrow transplantation is remarkable achievement of medical science: Dr Farrukh Ali Khan - Press Release issued by Dow University of Health Sciences. Oct 17, 2019 337
Use of Novel Therapy, Stem Cell Transplant in MM Varies by Race; African-Americans, Hispanics have longer time from MM diagnosis to novel therapy initiation than whites. Oct 17, 2019 267
MorphoSys--MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China--14/1/2019. Oct 17, 2019 413
Senga is a truly deserving winner; Supergran is always there for everyone else. GREGOR FARQUHARSON Oct 16, 2019 318
I-Mab to expand ongoing phase II and III clinical trials of TJ202/MOR202 into China under fast-to-market development strategy. Oct 14, 2019 251
I-Mab to expand ongoing phase II and III clinical trials of TJ202/MOR202 into China under fast-to-market development strategy. Oct 14, 2019 247
MorphoSys, I-Mab Biopharma announce IND approval to initiate trials. Oct 14, 2019 197
Viagra Could Help Combat Blood Cancer Soon. Johnny Vatican Oct 11, 2019 610
Concert to honour mum. Oct 9, 2019 139
Family of Scottish woman who died of blood cancer to host rock concert fundraiser. Oct 9, 2019 482
Nektar Hit With Double Downgrade From Goldman: 'Significant Challenges In Rebuilding Confidence'. Shanthi Rexaline Oct 8, 2019 562
Bone Cancer Market Scenario 2019 Size, Share, Industry Growth, Current & Future Prospect, Key Venders, Exclusive Research by Cancer Industry Till 2022. Oct 8, 2019 831
PS6k boost for Peter's blood cancer drive. Oct 3, 2019 556
Care at High-Volume Facility May Cut Mortality in Multiple Myeloma; Mortality did not differ for those treated by NCICCC MM specialists, highest-volume community oncologists. Oct 2, 2019 312
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation. Houston, B.L.; Rimmer, E.; Zarychanski, R.; Seftel, M. Oct 1, 2019 3115
An approach to the diagnosis and management of multiple myeloma. Fazel, F.; Bassa, F. Disease/Disorder overview Oct 1, 2019 3765
A Specialized Orthosis for Suppressing Bony Destruction from Multiple Myeloma and to Enhance Healing of a Pathologic Fracture in an Appendicular Lesion. Chisena, Ernest C.; Edelstein, Yudell; Chisena, Robert S. Oct 1, 2019 3337
Blood test can spot 20 types of cancer. GREGORY KIRBY Sep 28, 2019 104
Genmab receives FDA approval for DARZALEX in combination with bortezomib, thalidomide and dexamethasone for frontline multiple myeloma. Sep 27, 2019 235
Genmab receives FDA approval for DARZALEX in combination with bortezomib, thalidomide and dexamethasone for frontline multiple myeloma. Sep 27, 2019 236
Genmab receives FDA approval for DARZALEX in combination with bortezomib, thalidomide and dexamethasone for frontline multiple myeloma. Sep 27, 2019 231
Genmab announces FDA approval of Darzalex combination for FMM. Sep 26, 2019 240
Blood cancer battle call by Malton man. Sep 23, 2019 390
Simon Thomas admits he missed vital signs that his late wife had leukaemia; The former Blue Peter said his lack of knowledge about the symptoms of blood cancer meant he missed vital signs his wife was ill. Sep 19, 2019 597
Amgen (NASDAQ: AMGN) - Amgen Announces Phase 3 CANDOR Study Combining KYPROLIS[R] (carfilzomib) And DARZALEX[R] (daratumumab) Meets Primary Endpoint Of Progression-Free Survival -- 13/9/2019. Sep 19, 2019 365
Kyphoplasty Systems Market Became a Highly Profitable Industry: Revenue Analysis and Industry Foreca. Sep 17, 2019 881
Glenmark Pharmaceuticals wins the FDA orphan drug designation for GBR 1342 to treat multiple myeloma. Sep 17, 2019 258
Glenmark Pharmaceuticals wins the FDA orphan drug designation for GBR 1342 to treat multiple myeloma. Sep 17, 2019 254
Genmab reports positive topline results in phase III study of daratumumab in combination with carfilzomib and dexamethasone in relapsed or refractory multiple myeloma. Report Sep 16, 2019 242
Genmab reports positive topline results in phase III study of daratumumab in combination with carfilzomib and dexamethasone in relapsed or refractory multiple myeloma. Report Sep 16, 2019 238
Karyopharm, Healthcare Royalty Partners enter royalty agreement up to $150M. Sep 16, 2019 324
Cellectar Biosciences presents data from Cohort 6 of CLR 131 Phase 1 study. Sep 16, 2019 336
Low-cost arthritis drug could treat patients with blood cancers. Sep 16, 2019 379
Kyphoplasty Systems Market Became a Highly Profitable Industry: Revenue Analysis and Industry Foreca. Sep 16, 2019 896
Amgen says Phase 3 CANDOR study met primary endpoint. Sep 13, 2019 143
Genmab reports Phase 3 CANDOR study met primary endpoint. Sep 13, 2019 227
Vietnam vet death link to jungle spray. Sep 10, 2019 105
Little boy's heartbreaking words to dying dad who can't get drug he needs on NHS; EXCLUSIVE: Adam Thornton, from Chatham, Kent, was diagnosed with Multiple Myeloma, a blood cancer, after suffering back pain but cannot get Revlimid on the NHS. Sep 7, 2019 1437
Dad in drive to survive; Car rally: Blood cancer patient appeals for people to join stem cell register. Sep 6, 2019 336
QCS's blood cancer awareness campaign concludes. Sep 6, 2019 225
US FDA grants orphan drug designation to CARsgen Therapeutics' multiple myeloma therapy. Sep 2, 2019 218
US FDA grants orphan drug designation to CARsgen Therapeutics' multiple myeloma therapy. Sep 2, 2019 214
I'm running for my pals ... and baby Abbie too; FIREFIGHTER GRAEME TO BOOST BATTLE AGAINST BLOOD CANCER. Sep 2, 2019 494
CARsgen Therapeutics Inc wins US FDA orphan drug designation for investigational ct053 for multiple myeloma treatment. Sep 2, 2019 195
CARsgen Therapeutics Inc wins US FDA orphan drug designation for investigational ct053 for multiple myeloma treatment. Sep 2, 2019 191
I've been no very well.. but I feel fine now that my sister has saved my life; RIVER CITY STAR ON HIS MISSION TO RAISE AWARENESS OF STEMCELL DONATION AFTER BLOOD CANCER DIAGNOSIS; Panto legend thanks sibling for helping him fight leukaemia. Sep 1, 2019 1131
European Commission Approves Empliciti Plus Pomalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma. Aug 30, 2019 777
Celgene Corporation (NASDAQ: CELG) - U.S. FDA Approves INREBIC[R] (Fedratinib) as First New Treatment in Nearly a Decade for Patients With Myelofibrosis -- 16/8/2019. Aug 29, 2019 781
Blood cancer patient speaks out to save lives; Healthcare: Importance of recognising symptoms. Aug 28, 2019 323
GlaxoSmithKline (LSE: GSK) - GSK announces positive headline results from the pivotal DREAMM-2 study for multiple myeloma -- 23/8/2019. Aug 27, 2019 274
Kyphoplasty Systems Market 2018 to 2028 Shares, Trend and Growth Report. Aug 24, 2019 1110
Genmab receives approval of DARZALEX for frontline multiple myeloma in Japan. Aug 23, 2019 313
Genmab receives approval of DARZALEX for frontline multiple myeloma in Japan. Aug 23, 2019 314
Genmab receives approval of DARZALEX for frontline multiple myeloma in Japan. Aug 23, 2019 309
GlaxoSmithKline's Dreamm-2 Multiple Myeloma Trial Results Encouraging. Aug 23, 2019 210
Novel Therapy Treats Triple-Class Refractory Multiple Myeloma; Partial response or better observed in 26 percent of patients receiving oral selinexor-dexamethasone. Aug 23, 2019 279
Drug Offers Hope Against a Tough-to-Treat Blood Cancer. Aug 21, 2019 558
Karyopharm selinexor phase 2b data published in NEJM saw 26% response rate. Aug 21, 2019 291
Patient Preferences Explored in Multiple Myeloma Treatment; All-oral regimen linked to higher satisfaction with treatment convenience in relapsed, refractory MM. Aug 20, 2019 260
SAVED Score Can Predict Risk for VTE in Multiple Myeloma; Score outperforms current NCCN guidelines for MM patients receiving immunomodulatory therapy. Aug 16, 2019 253
CASI Pharmaceuticals Announces Launch of EVOMELAA[R] (melphalan for injection) in China. Aug 12, 2019 1098
PS4m boost for uni research. Aug 8, 2019 358
New Study Finds a Family Risk for Blood Cancer. Aug 8, 2019 331
New Score Predicts Risk for VTE in Those With Multiple Myeloma; New IMPEDE VTE score outperforms International Myeloma Working Group/NCCN guidelines. Aug 7, 2019 272
Karyopharm reports Q2 EPS (71c), consensus (98c). Financial report Aug 6, 2019 187
Karyopharm expects cash, cash equivalents to fund operations into 2H20. Aug 6, 2019 101
New initiative to provide medicines to needy patients. Aug 3, 2019 283
THE LAST STAND: When things are not going your way, never say die--it's always worth it. Berriochoa, Emily Schuh; Schuh, Dwight Aug 1, 2019 2278
Deep Venous Thrombosis in Patients with Erythema Nodosum Leprosum in the Use of Thalidomide and Systemic Corticosteroid in Reference Service in Belo Horizonte, Minas Gerais. Porto, Luiz Alberto Bomjardim; Grossi, Maria Aparecida de Faria; de Alecrim, Edilamar Silva; Xavier, Jul 31, 2019 3019
Colon Cancer with Streptococcus gallolyticus Aortic Valve Endocarditis: A Missing Link? Chime, Chukwunonso; Patel, Harish; Kumar, Kishore; Elwan, Ahmed; Bhandari, Manoj; Ihimoyan, Ariyo Jul 31, 2019 2290
Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Empliciti Plus Pomalidomide and Low-Dose Dexamethasone for Treatment of Patients with Relapsed and Refractory Multiple Myeloma. Jul 30, 2019 491
Bristol-Myers Squibb (NYSE:BIVIY) - Bristol-IVIyers Squibb Receives Positive CHMP Opinion Recommending Approval of Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone for Treatment of Patients with Relapsed and Refractory Multiple Myeloma -- 26/7/2019. Jul 29, 2019 249
Bristol-Myers' Emplicit combination for myeloma granted positive CHMP opinion. Jul 26, 2019 170
Bristol-Myers announces positive CHMP opinion for Empliciti combination. Jul 26, 2019 143
Bunbury blood cancer dad gets boost from energetic friends; Three hour exercise session to raise awareness and encourage possible donors to register. Jul 23, 2019 479
Bunbury blood cancer dad gets boost from energetic friends; Three hour exercise session to raise awareness and encourage possible donors to register. Jul 23, 2019 479
MGUS Can Progress to Multiple Myeloma Within Five Years; Risk factors associated with progression include IgA isotype, 15 g/L or more monoclonal spike. Jul 23, 2019 278
Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of Darzalex. Jul 22, 2019 750
Depression at Time of Diagnosis May Worsen Survival in Blood Cancers; Risk for death higher even with depression remission versus never experiencing depression. Jul 16, 2019 230
Janssen submits BLA to US FDA seeking approval of new DARZALEX (daratumumab) subcutaneous formulation for multiple myeloma. Jul 15, 2019 340
US FDA receives Biologics License Application from Janssen Pharmaceutical for DARZALEX. Jul 15, 2019 158
Janssen submits BLA to US FDA seeking approval of new DARZALEX (daratumumab) subcutaneous formulation for multiple myeloma. Jul 15, 2019 336
US FDA receives Biologics License Application from Janssen Pharmaceutical for DARZALEX. Jul 15, 2019 154
Xpovio Available for Order at Biologics by McKesson. Jul 11, 2019 380
Deciphera Pharmaceuticals Names Susan L. Kelley, M.D., to its Board of Directors. Jul 11, 2019 342
Xpovio With Dexamethasone Approved for Refractory Multiple Myeloma. Jul 10, 2019 253
Xpovio With Dexamethasone Approved for Refractory Multiple Myeloma; Drug combination approved to treat patients who have failed at least five other treatments. Jul 9, 2019 253
Genmab reports positive topline results in the phase II GRIFFIN study. Report Jul 9, 2019 350
Genmab reports positive topline results in the phase II GRIFFIN study. Report Jul 9, 2019 351
Genmab says Phase II GRIFFIN study met primary endpoint. Jul 8, 2019 187
Mum is rocked by blood cancer diagnosis weeks into pregnancy. Jul 5, 2019 700
The US Food and Drug Administration grants accelerated approval to Xpovio tablets in combination with corticosteroid dexamethasone. Jul 5, 2019 208
The US Food and Drug Administration grants accelerated approval to Xpovio tablets in combination with corticosteroid dexamethasone. Jul 5, 2019 204
Karyopharm approval label for Xpovio 'compelling,' says H.C. Wainwright. Jul 5, 2019 129
Wedbush boosts Karyopharm target to $11 from $6 on Xpovio approval. Jul 5, 2019 133
Fly Intel: Pre-market Movers. Jul 5, 2019 218
FDA approves Xpovio and dexamethasone for refractory multiple myeloma. Jul 4, 2019 262
FDA approves Xpovio and dexamethasone for refractory multiple myeloma. Jul 4, 2019 258
Johnson & Johnson (NYSE: JNJ) - Janssen Announces U.S. FDA Approval of DARZALEX[R] (daratumumab) in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Patients with Multiple Myeloma Who Are Transplant Ineligible -- 27/6/2019. Jul 4, 2019 492
Karyopharm jumps after website points to Xpovio approval. Jul 3, 2019 180
FDA confirms approval of Karyopharm treatment for refractory multiple myeloma. Jul 3, 2019 247
Karyopharm announces FDA approval of XPOVIO-dexamethasone combination. Jul 3, 2019 175
laughter is the best medicine. Kwasny, Emmalyne Jul 1, 2019 230
SPINAL ANESTHESIA AND INTERSCALENE / SUPERFICIAL CERVICAL BLOCK IN MULTIPLE MYELOMA PATHOLOGICAL FRACTURE. Bilge, Aysegul; Ancan, Sule Jul 1, 2019 1566
A Rare Presentation of Multiple Myeloma: A Case Report of Hepatic Amyloidosis. Sadeghi, Alireza; Nejati, Maliheh; Moghaddas, Azadeh Report Jul 1, 2019 2410
Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment. Zhang, Xiaonan; Espinosa, Belen; Saei, Amir Ata; D'Arcy, Padraig; Zubarev, Roman A.; Linder, Stig Jun 30, 2019 7172
Betulinic Acid Induces ROS-Dependent Apoptosis and S-Phase Arrest by Inhibiting the NF-[kappa]B Pathway in Human Multiple Myeloma. Shen, Min; Hu, Yiqiang; Yang, Yan; Wang, Lanlan; Yang, Xin; Wang, Bo; Huang, Mei Jun 30, 2019 6438
Do our own bodies hold the key to finding a cancer cure? LISA HUTCHINSON reports on a pioneering treatment which is offering new hope to patients with blood cancer by harnessing their own immune systems. Jun 28, 2019 1156
Genmab receives FDA approval of DARZALEX in combination with lenalidomide and dexamethasone in frontline multiple myeloma. Jun 28, 2019 270
Genmab receives FDA approval of DARZALEX in combination with lenalidomide and dexamethasone in frontline multiple myeloma. Jun 28, 2019 271
Genmab receives FDA approval of DARZALEX in combination with lenalidomide and dexamethasone in frontline multiple myeloma. Jun 28, 2019 266
SpringWorks Therapeutics Forges Global Clinical Collaboration with GlaxoSmithKline to Evaluate Nirogacestat in Combination with Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma. Jun 28, 2019 543
CARsgen Therapeutics wins FDA's IND clearance for CT053 for myeloma. Jun 20, 2019 218
CARsgen Therapeutics wins FDA's IND clearance for CT053 for myeloma. Jun 20, 2019 214
Bristol-Myers Squibb Presents Updated Efficacy Data from Phase 2 Trial of Empliciti Plus Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma. Clinical report Jun 18, 2019 676
Residents sign up to help blood cancer patients. Jun 17, 2019 347
Sutro Biopharma announces interim Phase 1 safety data for STRO-001. Jun 16, 2019 105

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters